Structure

Physi-Chem Properties

Molecular Weight:  436.19
Volume:  458.959
LogP:  5.772
LogD:  4.036
LogS:  -3.544
# Rotatable Bonds:  7
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.226
Synthetic Accessibility Score:  3.597
Fsp3:  0.269
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.948
MDCK Permeability:  1.7860123989521526e-05
Pgp-inhibitor:  0.656
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.016
30% Bioavailability (F30%):  0.023

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  101.1530990600586%
Volume Distribution (VD):  0.584
Pgp-substrate:  2.169116973876953%

ADMET: Metabolism

CYP1A2-inhibitor:  0.871
CYP1A2-substrate:  0.446
CYP2C19-inhibitor:  0.728
CYP2C19-substrate:  0.156
CYP2C9-inhibitor:  0.82
CYP2C9-substrate:  0.936
CYP2D6-inhibitor:  0.931
CYP2D6-substrate:  0.414
CYP3A4-inhibitor:  0.797
CYP3A4-substrate:  0.21

ADMET: Excretion

Clearance (CL):  11.359
Half-life (T1/2):  0.65

ADMET: Toxicity

hERG Blockers:  0.132
Human Hepatotoxicity (H-HT):  0.798
Drug-inuced Liver Injury (DILI):  0.178
AMES Toxicity:  0.104
Rat Oral Acute Toxicity:  0.769
Maximum Recommended Daily Dose:  0.913
Skin Sensitization:  0.948
Carcinogencity:  0.763
Eye Corrosion:  0.003
Eye Irritation:  0.651
Respiratory Toxicity:  0.884

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476981

Natural Product ID:  NPC476981
Common Name*:   (E)-1-[2-Methyl-2-(4-methyl-3-pentenyl)-5-hydroxy-8-methoxy-2H-1-benzopyran-6-yl]-3-(2,5-dihydroxyphenyl)-2-propene-1-one
IUPAC Name:   (E)-3-(2,5-dihydroxyphenyl)-1-[5-hydroxy-8-methoxy-2-methyl-2-(4-methylpent-3-enyl)chromen-6-yl]prop-2-en-1-one
Synonyms:  
Standard InCHIKey:  VSHVGAUGDJWOFM-VQHVLOKHSA-N
Standard InCHI:  InChI=1S/C26H28O6/c1-16(2)6-5-12-26(3)13-11-19-24(30)20(15-23(31-4)25(19)32-26)22(29)9-7-17-14-18(27)8-10-21(17)28/h6-11,13-15,27-28,30H,5,12H2,1-4H3/b9-7+
SMILES:  CC(=CCCC1(C=CC2=C(C(=CC(=C2O1)OC)C(=O)/C=C/C3=C(C=CC(=C3)O)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   122185280
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003472] 2'-Hydroxychalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33641 Desmodium congestum Species Fabaceae Eukaryota whole plant tropical rainforest surrounding villages near Bintulu, Sarawak, Malaysia 2014-SEP PMID[26284978]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT71 Cell Line HEK293 Homo sapiens IC50 = 21000 nM PMID[26284978]
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 32 ug/ml PMID[26284978]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 32 ug/ml PMID[26284978]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 32 ug/ml PMID[26284978]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 16 ug/ml PMID[26284978]
NPT1531 Organism Enterococcus faecium Enterococcus faecium MIC = 32 ug/ml PMID[26284978]
NPT19 Organism Escherichia coli Escherichia coli MIC > 32 ug/ml PMID[26284978]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476981 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9868 High Similarity NPC476980
0.9739 High Similarity NPC472448
0.9739 High Similarity NPC83922
0.9673 High Similarity NPC167678
0.9673 High Similarity NPC29876
0.9673 High Similarity NPC259456
0.9673 High Similarity NPC258331
0.9669 High Similarity NPC472455
0.9667 High Similarity NPC280937
0.9664 High Similarity NPC226973
0.9664 High Similarity NPC208043
0.9664 High Similarity NPC308451
0.961 High Similarity NPC261470
0.961 High Similarity NPC229632
0.9608 High Similarity NPC204290
0.9605 High Similarity NPC36852
0.9605 High Similarity NPC262286
0.9605 High Similarity NPC78225
0.9603 High Similarity NPC256612
0.9603 High Similarity NPC20830
0.9603 High Similarity NPC472280
0.9603 High Similarity NPC234255
0.9597 High Similarity NPC306821
0.9545 High Similarity NPC40037
0.9542 High Similarity NPC204879
0.9539 High Similarity NPC138243
0.9539 High Similarity NPC191146
0.9539 High Similarity NPC68093
0.9536 High Similarity NPC86485
0.9536 High Similarity NPC274327
0.9536 High Similarity NPC47781
0.9536 High Similarity NPC69394
0.9536 High Similarity NPC231018
0.9536 High Similarity NPC255350
0.9536 High Similarity NPC176775
0.9536 High Similarity NPC472408
0.9536 High Similarity NPC22519
0.9536 High Similarity NPC472915
0.9536 High Similarity NPC183878
0.9536 High Similarity NPC145379
0.9536 High Similarity NPC160951
0.9533 High Similarity NPC149614
0.9533 High Similarity NPC117579
0.9533 High Similarity NPC262623
0.953 High Similarity NPC328119
0.9487 High Similarity NPC275780
0.9487 High Similarity NPC50960
0.9487 High Similarity NPC239752
0.9487 High Similarity NPC472450
0.9484 High Similarity NPC81679
0.9481 High Similarity NPC246478
0.9477 High Similarity NPC181960
0.9477 High Similarity NPC217677
0.9477 High Similarity NPC473272
0.9477 High Similarity NPC474681
0.9477 High Similarity NPC284820
0.9477 High Similarity NPC218313
0.9477 High Similarity NPC165977
0.9474 High Similarity NPC163780
0.9474 High Similarity NPC117992
0.9474 High Similarity NPC113906
0.9474 High Similarity NPC230149
0.9474 High Similarity NPC39184
0.9474 High Similarity NPC50715
0.9474 High Similarity NPC167815
0.9474 High Similarity NPC472909
0.9474 High Similarity NPC134287
0.9474 High Similarity NPC201136
0.9474 High Similarity NPC227325
0.9474 High Similarity NPC130589
0.9474 High Similarity NPC213622
0.9474 High Similarity NPC37392
0.9474 High Similarity NPC208197
0.9474 High Similarity NPC57674
0.9474 High Similarity NPC2476
0.9474 High Similarity NPC146165
0.9474 High Similarity NPC256925
0.9474 High Similarity NPC4455
0.9474 High Similarity NPC280339
0.9474 High Similarity NPC138360
0.9474 High Similarity NPC92659
0.9474 High Similarity NPC152951
0.9474 High Similarity NPC196439
0.9474 High Similarity NPC32557
0.9474 High Similarity NPC168247
0.9474 High Similarity NPC183597
0.9474 High Similarity NPC189960
0.9474 High Similarity NPC128863
0.947 High Similarity NPC275722
0.947 High Similarity NPC301323
0.947 High Similarity NPC83508
0.947 High Similarity NPC162313
0.947 High Similarity NPC275836
0.947 High Similarity NPC166201
0.947 High Similarity NPC256283
0.947 High Similarity NPC471982
0.947 High Similarity NPC60972
0.947 High Similarity NPC237994
0.947 High Similarity NPC25270
0.947 High Similarity NPC241498
0.947 High Similarity NPC131624
0.947 High Similarity NPC198826
0.947 High Similarity NPC39732
0.947 High Similarity NPC239128
0.947 High Similarity NPC120163
0.947 High Similarity NPC100887
0.947 High Similarity NPC187498
0.947 High Similarity NPC301123
0.947 High Similarity NPC293183
0.947 High Similarity NPC71334
0.947 High Similarity NPC212678
0.947 High Similarity NPC188203
0.947 High Similarity NPC57030
0.947 High Similarity NPC156222
0.947 High Similarity NPC222830
0.9467 High Similarity NPC179183
0.9467 High Similarity NPC239363
0.9467 High Similarity NPC156953
0.9463 High Similarity NPC195202
0.9427 High Similarity NPC39091
0.9427 High Similarity NPC120593
0.9423 High Similarity NPC23298
0.9423 High Similarity NPC189473
0.9423 High Similarity NPC306321
0.9423 High Similarity NPC303460
0.9419 High Similarity NPC66288
0.9419 High Similarity NPC266314
0.9419 High Similarity NPC474187
0.9419 High Similarity NPC61010
0.9416 High Similarity NPC250214
0.9416 High Similarity NPC152904
0.9416 High Similarity NPC95936
0.9416 High Similarity NPC184755
0.9416 High Similarity NPC74178
0.9412 High Similarity NPC178854
0.9412 High Similarity NPC276444
0.9412 High Similarity NPC133970
0.9412 High Similarity NPC6633
0.9412 High Similarity NPC472916
0.9412 High Similarity NPC5322
0.9412 High Similarity NPC49824
0.9412 High Similarity NPC471985
0.9408 High Similarity NPC128961
0.9408 High Similarity NPC250822
0.9408 High Similarity NPC49402
0.9408 High Similarity NPC206238
0.9408 High Similarity NPC70433
0.9408 High Similarity NPC75279
0.9408 High Similarity NPC88645
0.9408 High Similarity NPC33051
0.9408 High Similarity NPC167091
0.9408 High Similarity NPC292214
0.9408 High Similarity NPC227337
0.9408 High Similarity NPC271779
0.9408 High Similarity NPC273462
0.9408 High Similarity NPC276409
0.9408 High Similarity NPC124714
0.9404 High Similarity NPC154345
0.94 High Similarity NPC266499
0.9396 High Similarity NPC93034
0.9396 High Similarity NPC62536
0.9396 High Similarity NPC12200
0.9396 High Similarity NPC119660
0.9396 High Similarity NPC33265
0.9396 High Similarity NPC205522
0.9359 High Similarity NPC329760
0.9359 High Similarity NPC474162
0.9359 High Similarity NPC474150
0.9355 High Similarity NPC228785
0.9355 High Similarity NPC328102
0.9355 High Similarity NPC474287
0.9355 High Similarity NPC475784
0.9355 High Similarity NPC119209
0.9355 High Similarity NPC14353
0.9355 High Similarity NPC118256
0.9355 High Similarity NPC192686
0.9355 High Similarity NPC475886
0.9355 High Similarity NPC56085
0.9351 High Similarity NPC210084
0.9351 High Similarity NPC475267
0.9351 High Similarity NPC78103
0.9351 High Similarity NPC93376
0.9351 High Similarity NPC470402
0.9351 High Similarity NPC110070
0.9351 High Similarity NPC227192
0.9351 High Similarity NPC203891
0.9351 High Similarity NPC472910
0.9351 High Similarity NPC474208
0.9351 High Similarity NPC291508
0.9351 High Similarity NPC75215
0.9351 High Similarity NPC224137
0.9351 High Similarity NPC474836
0.9351 High Similarity NPC101830
0.9351 High Similarity NPC52889
0.9351 High Similarity NPC96167
0.9351 High Similarity NPC472914
0.9351 High Similarity NPC245758
0.9351 High Similarity NPC223787
0.9351 High Similarity NPC99597
0.9351 High Similarity NPC472911

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476981 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9536 High Similarity NPD2801 Approved
0.9156 High Similarity NPD2393 Clinical (unspecified phase)
0.9091 High Similarity NPD1934 Approved
0.9007 High Similarity NPD4378 Clinical (unspecified phase)
0.8987 High Similarity NPD5494 Approved
0.894 High Similarity NPD1511 Approved
0.8917 High Similarity NPD3882 Suspended
0.8824 High Similarity NPD1512 Approved
0.8773 High Similarity NPD3818 Discontinued
0.8758 High Similarity NPD7410 Clinical (unspecified phase)
0.8734 High Similarity NPD3817 Phase 2
0.8718 High Similarity NPD4380 Phase 2
0.865 High Similarity NPD6168 Clinical (unspecified phase)
0.865 High Similarity NPD6166 Phase 2
0.865 High Similarity NPD6167 Clinical (unspecified phase)
0.8642 High Similarity NPD6232 Discontinued
0.8598 High Similarity NPD7473 Discontinued
0.858 High Similarity NPD1247 Approved
0.8533 High Similarity NPD1510 Phase 2
0.8512 High Similarity NPD4338 Clinical (unspecified phase)
0.8509 High Similarity NPD7075 Discontinued
0.8494 Intermediate Similarity NPD5844 Phase 1
0.8494 Intermediate Similarity NPD7054 Approved
0.8487 Intermediate Similarity NPD1549 Phase 2
0.8477 Intermediate Similarity NPD2796 Approved
0.8447 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD7472 Approved
0.8443 Intermediate Similarity NPD7074 Phase 3
0.8438 Intermediate Similarity NPD7819 Suspended
0.8438 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD1240 Approved
0.8375 Intermediate Similarity NPD6801 Discontinued
0.8355 Intermediate Similarity NPD2935 Discontinued
0.8313 Intermediate Similarity NPD7411 Suspended
0.8294 Intermediate Similarity NPD7808 Phase 3
0.8284 Intermediate Similarity NPD6797 Phase 2
0.8278 Intermediate Similarity NPD1607 Approved
0.8272 Intermediate Similarity NPD5402 Approved
0.8272 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD7251 Discontinued
0.8232 Intermediate Similarity NPD919 Approved
0.8217 Intermediate Similarity NPD6799 Approved
0.8166 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD943 Approved
0.8144 Intermediate Similarity NPD3926 Phase 2
0.8133 Intermediate Similarity NPD6959 Discontinued
0.8098 Intermediate Similarity NPD1465 Phase 2
0.8077 Intermediate Similarity NPD2800 Approved
0.8025 Intermediate Similarity NPD3750 Approved
0.8025 Intermediate Similarity NPD6599 Discontinued
0.8023 Intermediate Similarity NPD6559 Discontinued
0.8013 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7768 Phase 2
0.7988 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7974 Intermediate Similarity NPD447 Suspended
0.7965 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD3749 Approved
0.795 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD920 Approved
0.7937 Intermediate Similarity NPD2532 Approved
0.7937 Intermediate Similarity NPD2533 Approved
0.7937 Intermediate Similarity NPD2534 Approved
0.7895 Intermediate Similarity NPD2313 Discontinued
0.7853 Intermediate Similarity NPD3226 Approved
0.7848 Intermediate Similarity NPD1243 Approved
0.784 Intermediate Similarity NPD5403 Approved
0.7826 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD2799 Discontinued
0.7821 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7814 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1551 Phase 2
0.7763 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD5953 Discontinued
0.7746 Intermediate Similarity NPD7286 Phase 2
0.7742 Intermediate Similarity NPD230 Phase 1
0.7722 Intermediate Similarity NPD2344 Approved
0.7722 Intermediate Similarity NPD2346 Discontinued
0.7722 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD5401 Approved
0.7707 Intermediate Similarity NPD3748 Approved
0.7702 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6651 Approved
0.7688 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD1613 Approved
0.7677 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD6100 Approved
0.7658 Intermediate Similarity NPD6099 Approved
0.7654 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD1933 Approved
0.7597 Intermediate Similarity NPD3027 Phase 3
0.7595 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3751 Discontinued
0.7578 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD4628 Phase 3
0.7576 Intermediate Similarity NPD1653 Approved
0.7546 Intermediate Similarity NPD7390 Discontinued
0.7542 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD2309 Approved
0.7531 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD37 Approved
0.75 Intermediate Similarity NPD7199 Phase 2
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7471 Intermediate Similarity NPD4965 Approved
0.7471 Intermediate Similarity NPD4967 Phase 2
0.7471 Intermediate Similarity NPD4966 Approved
0.7468 Intermediate Similarity NPD9494 Approved
0.7457 Intermediate Similarity NPD3787 Discontinued
0.7451 Intermediate Similarity NPD1203 Approved
0.7436 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD6779 Approved
0.7433 Intermediate Similarity NPD6780 Approved
0.7433 Intermediate Similarity NPD6781 Approved
0.7433 Intermediate Similarity NPD6777 Approved
0.7433 Intermediate Similarity NPD6782 Approved
0.7433 Intermediate Similarity NPD6776 Approved
0.7433 Intermediate Similarity NPD6778 Approved
0.7414 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD5242 Approved
0.7403 Intermediate Similarity NPD8434 Phase 2
0.7403 Intermediate Similarity NPD2798 Approved
0.7396 Intermediate Similarity NPD6844 Discontinued
0.7375 Intermediate Similarity NPD4308 Phase 3
0.7375 Intermediate Similarity NPD7033 Discontinued
0.7372 Intermediate Similarity NPD4625 Phase 3
0.7366 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5711 Approved
0.7356 Intermediate Similarity NPD5710 Approved
0.7351 Intermediate Similarity NPD4363 Phase 3
0.7351 Intermediate Similarity NPD4360 Phase 2
0.7333 Intermediate Similarity NPD8313 Approved
0.7333 Intermediate Similarity NPD8312 Approved
0.7325 Intermediate Similarity NPD3268 Approved
0.7318 Intermediate Similarity NPD7685 Pre-registration
0.7316 Intermediate Similarity NPD7435 Discontinued
0.7316 Intermediate Similarity NPD7696 Phase 3
0.7316 Intermediate Similarity NPD7697 Approved
0.7316 Intermediate Similarity NPD7698 Approved
0.7308 Intermediate Similarity NPD8150 Discontinued
0.7308 Intermediate Similarity NPD6832 Phase 2
0.7308 Intermediate Similarity NPD4908 Phase 1
0.7303 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD7584 Approved
0.7278 Intermediate Similarity NPD7549 Discontinued
0.7277 Intermediate Similarity NPD7871 Phase 2
0.7277 Intermediate Similarity NPD7870 Phase 2
0.7273 Intermediate Similarity NPD2403 Approved
0.7267 Intermediate Similarity NPD1548 Phase 1
0.7257 Intermediate Similarity NPD7229 Phase 3
0.7255 Intermediate Similarity NPD9717 Approved
0.7235 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD6386 Approved
0.7235 Intermediate Similarity NPD6385 Approved
0.7229 Intermediate Similarity NPD4357 Discontinued
0.7226 Intermediate Similarity NPD1470 Approved
0.7226 Intermediate Similarity NPD2797 Approved
0.7219 Intermediate Similarity NPD4361 Phase 2
0.7219 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7458 Discontinued
0.7209 Intermediate Similarity NPD5353 Approved
0.72 Intermediate Similarity NPD5536 Phase 2
0.7191 Intermediate Similarity NPD7228 Approved
0.719 Intermediate Similarity NPD422 Phase 1
0.719 Intermediate Similarity NPD1610 Phase 2
0.7188 Intermediate Similarity NPD5124 Phase 1
0.7188 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD6823 Phase 2
0.7166 Intermediate Similarity NPD6534 Approved
0.7166 Intermediate Similarity NPD6535 Approved
0.7165 Intermediate Similarity NPD7701 Phase 2
0.7143 Intermediate Similarity NPD1608 Approved
0.7143 Intermediate Similarity NPD7783 Phase 2
0.7143 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD9269 Phase 2
0.7134 Intermediate Similarity NPD2424 Discontinued
0.7134 Intermediate Similarity NPD2861 Phase 2
0.7134 Intermediate Similarity NPD3018 Phase 2
0.7128 Intermediate Similarity NPD8151 Discontinued
0.7125 Intermediate Similarity NPD4307 Phase 2
0.7118 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD5404 Approved
0.7117 Intermediate Similarity NPD5406 Approved
0.7117 Intermediate Similarity NPD5405 Approved
0.7117 Intermediate Similarity NPD5408 Approved
0.7111 Intermediate Similarity NPD1729 Discontinued
0.711 Intermediate Similarity NPD4288 Approved
0.7107 Intermediate Similarity NPD411 Approved
0.7107 Intermediate Similarity NPD3764 Approved
0.7105 Intermediate Similarity NPD9268 Approved
0.7097 Intermediate Similarity NPD4749 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data